From: Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT
Ductal/lobular (n)
8/2
ER+/HER2 2+ (n)
5
ER-/HER2 2+ (n)
0
ER+/HER2-
4
ER-/HER2- (triple neg.)
1
Grade 1/2/3 (n)
1/5/4